Related Experiment Videos
Leukemia drug heralds molecularly targeted era
Journal of the National Cancer Institute
|January 6, 2000
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Expanding the phenotype of hereditary renal cell carcinoma syndromes: Implications for surveillance and management.
Journal of the National Cancer Institute·2026
Periductal myxoid stroma identifies ductal carcinoma in situ at risk of invasive recurrence.
Journal of the National Cancer Institute·2026
Anal cancer burden among people with HIV across US states, DC, and major metro areas.
Journal of the National Cancer Institute·2026
Benchmarking female breast cancer survival in africa, Central and South america, and asia (SURVCAN-3).
Journal of the National Cancer Institute·2026
Reproducibility of overall survival in metastatic colorectal cancer randomized trials using ARCAD-Derived external control arms.
Journal of the National Cancer Institute·2026
Endocrine therapy in early-stage estrogen Receptor-Low breast cancer: a systematic review and Meta-Analysis.
Journal of the National Cancer Institute·2026
Polycation chain length determines the in vivo mRNA delivery efficiency of block copolymer micelles.
Biomaterials science·2026
Driving Drugs Deeper: Force-Driven Microneedle Systems for Active Therapy and Their Road Towards Clinical Implementation.
Small (Weinheim an der Bergstrasse, Germany)·2026
Mumio Potentiates Temozolomide by Inducing Apoptosis and Ferroptosis in Glioblastoma Cells.
Current pharmaceutical design·2026
Current Targeted Nanoparticle Therapy for Alzheimer's Disease: Current Advances and Future Prospects.
Current neurovascular research·2026
Clinical Presentation, Diagnosis, Treatment, and Outcome of Heart Disease in Becker Muscular Dystrophy.
Anatolian journal of cardiology·2026
Clinical Pharmacology of Eplontersen, the First Approved GalNAc-Conjugated Antisense Oligonucleotide.
Journal of clinical pharmacology·2026